## Abstract The objective was to provide population‐based estimates of incremental medical costs associated with Parkinson's disease (PD) from onset forward. All Olmsted County, Minnesota, residents with confirmed PD onset from 1987 through 1995 (n = 92) and one age‐ and sex‐matched non‐PD referent
Comorbid conditions associated with Parkinson's disease: A population-based study
✍ Scribed by Cynthia L. Leibson; Demetrius M. Maraganore; James H. Bower; Jeanine E. Ransom; Peter C. O'Brien; Walter A. Rocca
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 112 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The burden of comorbidity in Parkinson's disease (PD) remains unclear. All Olmsted County, Minnesota, residents with incident PD in 1976–1995 (n = 197) plus one age‐ and sex‐matched non‐PD referent subject per case were followed for all clinical diagnoses from 5 years before through 15 years after index (i.e., year of PD onset for each case and same year for the referent subject). Both members of a case–referent pair were censored at death or emigration of either member to ensure equivalent follow‐up. Cases and referent subjects were compared for summary comorbidity (Charlson index) and for the likelihood of having one or more diagnoses within each International Classification of Diseases chapter/subchapter. Before index, the groups were similar for all comparisons. After index, cases had a higher likelihood of diagnoses within the chapters “Mental Disorders” and “Diseases of the Genitourinary System,” and within the subchapters “Organic Psychotic Conditions,” “Other Psychoses,” “Neurotic/Personality/Other Nonpsychotic Disorders,” “Hereditary/Degenerative Diseases of Central Nervous System,” “Symptoms,” “Other Diseases of Digestive System,” “Other Diseases of Urinary System,” “Diseases of Veins/Lymphatics/Other Circulatory System Diseases,” “Fractures of Lower Limb,” “Other Diseases of Skin/Subcutaneous Tissue,” “Osteopathies/Chrondropathies/Acquired Musculoskeletal Deformities,” and “Pneumonia and Influenza.” The excess morbidity and mortality observed for persons with PD are consistent with recognized PD sequelae. © 2005 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract Most studies of mortality in Parkinson's disease have been clinical studies, yielding results that are not representative of the general population. We assessed the risk of mortality from Parkinson's disease in the Neurological Disorders in Central Spain (NEDICES) study, a prospective p
## Abstract Data on the incidence of Parkinson's disease (PD) and atypical parkinsonian syndromes (APS) in East European countries and Asia are limited. The objective of this prospective population‐based study was to determine the incidence of PD and APS in the Russian population. The study area wa
## Abstract The putative association between pesticide exposures and Parkinson's disease (PD) remains controversial. We identified all subjects who developed PD in Olmsted County, Minnesota, from 1976 through 1995, and matched them by age (± 1 year) and sex to general population controls. We assess
## Abstract The differential diagnosis of parkinsonian disorders is difficult, especially early in the course of the diseases. The clinical subtypes of Parkinson's disease (PD) have not so far been described in newly diagnosed patients. We present a prospective incidence cohort study of patients wi
## Abstract Alpha‐synuclein gene (__SNCA__) mutations cause familial Parkinsonism but the role of __SNCA__ variability in idiopathic Parkinson's disease (PD) remains incompletely defined. We report a study of __SNCA__ genetic variation in 452 idiopathic PD cases and 245 controls. __SNCA__ copy numb